Page last updated: 2024-10-30

mecamylamine and Brain Injuries

mecamylamine has been researched along with Brain Injuries in 2 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Brain Injuries: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersson, DR1
Björnsson, E1
Bergquist, F1
Nissbrandt, H1
Griffith, ER1
Taylor, N1
DeLateur, BJ1
Lehmann, JF1

Other Studies

2 other studies available for mecamylamine and Brain Injuries

ArticleYear
Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.
    Experimental neurology, 2010, Volume: 221, Issue:1

    Topics: Analysis of Variance; Animals; Area Under Curve; Brain Injuries; Chromatography, High Pressure Liqui

2010
Orthostatic hypertension following brain trauma: report of a case.
    Archives of physical medicine and rehabilitation, 1971, Volume: 52, Issue:8

    Topics: Adolescent; Brain Edema; Brain Injuries; Follow-Up Studies; Guanethidine; Hematoma, Subdural; Humans

1971